Galapagos



Ebit Endring Dato
argenx SE USD 14.19M 28.62M 2024-09
AstraZeneca USD 4.8B 604M 2025-03
Biogen USD 644.1M 100.9M 2024-12
Genmab DKK 2.16B 58M 2024-12
Gilead Sciences USD 2.89B 221M 2025-03
GlaxoSmithKline GBP 2.53B 1.1B 2025-03
GRIFOLS EUR 226.41M 43.08M 2024-12
Hikma Pharmaceutical USD 402M 96M 2024-06
Incyte USD 283.64M 92.62M 2025-03
Merck EUR 868M 229M 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 4.86B 286M 2024-12
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.9B 824M 2025-03
UCB EUR 334M 163M 2024-06
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



Galapagos - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.